Boston Scientific Faces Stock Plunge After Cybersecurity Incident

• •Boston Scientific's stock fell over 9% following a cybersecurity incident.
• •The company revised its 2026 outlook, expecting lower sales growth and earnings.
• •The cyber incident impacted multiple divisions, complicating performance analysis.

Boston Scientific's stock dropped significantly after the company revised its 2026 financial outlook due to a cybersecurity incident that occurred in August. The company now expects only 3.75% organic sales growth, down from a previous estimate of 5% to 6%. Analysts noted that the cyber incident affected multiple divisions, including electrophysiology and interventional cardiology. The fourth quarter is projected to see a sales decline of 1% to 3%, with earnings estimates dropping to 77-79 cents per share. The incident has led to a premarket stock decline of over 9%, potentially marking a four-year low for the shares. The specific details of the cyberattack, including the attack vector and the nature of the breach, were not disclosed in the articles.